Just a day after introducing its plans for overhauling the EU pharmaceutical legislation, the European Commission has launched another set of major proposals, this time including a new EU-level system for issuing compulsory licences for crisis-related products such as medicines.
The "patent package" comprises four draft regulations that the commission says will complement Europe’s new unitary patent regime, which is...








